
A zzso zzso zzso zzso trial was performed to investigate the effects of zzso zzso zzso on the quality of life zzso zzso weight and survival of patients with advanced, zzso zzso zzso zzso was assessed at the start of treatment and at 4, 8 and 12 weeks, using the zzso zzso 255 patients were zzso to 320 zzso of MA daily or zzso for 12 zzso zzso patients were zzso at zzso 190 at 4 weeks zzso zzso MA zzso 150 at 8 weeks zzso zzso MA zzso and 112 at 12 weeks zzso 55; MA zzso A beneficial effect of MA on appetite loss was observed at week 4 zzso zzso zzso and possibly at week 8 zzso zzso zzso Further weight loss during treatment was significant only in the zzso zzso In the first 8 weeks, changes in mean global zzso were small and similar in both zzso By 12 weeks the decrease in mean global zzso was more pronounced in the MA group zzso zzso zzso which was related to a deterioration in physical function, while zzso function was not zzso Survival was not affected by MA, and zzso were zzso The results show that MA has a beneficial effect on appetite and that it may zzso weight loss with no adverse impact on survival and with mild zzso However, MA does not appear to improve global zzso as measured by the zzso zzso 

